Crossmark

An integrative systems genetic analysis of mammalian lipid metabolism

Crossref DOI link: https://doi.org/10.1038/s41586-019-0984-y

Published Online: 2019-02-27

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Parker, Benjamin L.

Calkin, Anna C.

Seldin, Marcus M.

Keating, Michael F.

Tarling, Elizabeth J.

Yang, Pengyi

Moody, Sarah C.

Liu, Yingying

Zerenturk, Eser J.

Needham, Elise J.

Miller, Matthew L.

Clifford, Bethan L.

Morand, Pauline

Watt, Matthew J.

Meex, Ruth C. R.

Peng, Kang-Yu

Lee, Richard

Jayawardana, Kaushala

Pan, Calvin

Mellett, Natalie A.

Weir, Jacquelyn M.

Lazarus, Ross

Lusis, Aldons J.

Meikle, Peter J.

James, David E.

de Aguiar Vallim, Thomas Q.

Drew, Brian G.
License Information

Text and Data Mining valid from 2019-02-27
More Information

Article History

Received: 2 March 2018

Accepted: 23 January 2019

First Online: 27 February 2019

Competing interests

: R. Lee holds shares in Ionis Pharmaceuticals. B.G.D., A.C.C., T.Q.d.A.V. and D.E.J. are inventors on patent PCT/AU2019/050033 pertaining to aspects of the PSMD9 work. All other authors declare no competing interests.